---

title: "Glymphatic System Dysregulation as a Key Contributor to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome"
tags:
- ðŸ§ª Biomarker
created: '2025-11-27'
published: '2025-11-27'

---


<details>
<summary>Nemat-Gorgani et al. (2025)</summary>

- **Authors:** Mohsen Nemat-Gorgani, Michael Anthony Jensen, Ronald Wayne Davis.
- **Institutes:** Stanford Genome Technology Center, Department of Biochemistry, Stanford University, Palo Alto, CA, USA.
- **Publisher:** International Journal of Molecular Sciences (IJMS)
- **Link:** [DOI](https://doi.org/10.3390/ijms262311524)

</details>


## Summary

This research introduces a compelling model that views ME/CFS as a "waste management" problem within the brain. It suggests that the profound fatigue and "brain fog" reported by patients are not just subjective feelings but may be the result of a physical accumulation of metabolic toxins that the brain is unable to wash away. By identifying the glymphatic system as a key player, this study provides a potential bridge between known issues like low blood flow and neuroinflammation. While more clinical trials are needed to confirm these findings, the focus on brain clearance opens a new frontier for developing objective tests and treatments aimed at restoring the brain's natural cleaning process.

## What was researched?

This paper explored the hypothesis that dysregulation of the glymphatic systemâ€”the brain's specialized waste-clearance mechanismâ€”is a central factor in the development and symptoms of ME/CFS. The researchers investigated how a failure in "cleaning" metabolic toxins from the central nervous system could explain the complex and diverse symptoms experienced by patients.

## Why was it researched?

Despite decades of study, ME/CFS lacks a definitive cause or a standard objective diagnostic test. Because the glymphatic system is primarily active during sleep to remove neurotoxic waste and has already been linked to other neurological conditions like Alzheimerâ€™s, the authors proposed that "clogging" of this system might be the missing link that connects hallmark symptoms like brain fog, sleep disturbances, and post-exertional malaise.

## How was it researched?

This was a comprehensive literature review and theoretical analysis that synthesized recent findings in neurobiology, immunology, and ME/CFS research. The authors analyzed evidence regarding cerebral blood flow, neuroinflammation, and the role of AQP4 water channels, which are critical for glymphatic flow. They integrated data from diverse areas, including gut-brain axis studies, oxidative stress research, and vascular dysfunction, to propose a unified model of how these factors converge to cause glymphatic system dysfunction (GD).

## What has been found?

The study proposes that glymphatic dysfunction is a major contributor to ME/CFS pathophysiology, suggesting that symptoms arise when the brain cannot effectively clear out metabolic byproducts like lactic acid. The authors identified several potential drivers of this dysfunction, including impaired cerebral blood flow (hypoxia), neuroinflammation, and the possible presence of autoantibodies targeting AQP4 water channels. They also highlighted how sleep disturbances create a "vicious cycle," where poor sleep prevents the glymphatic system from clearing waste, which in turn further disrupts sleep and cognitive function.

## Discussion

The authors discuss the significant overlap between ME/CFS and Long COVID, noting that glymphatic impairment may be a shared mechanism in both conditions. They acknowledge that while the evidence for glymphatic involvement is strong based on existing data, direct clinical proof in ME/CFS cohortsâ€”such as specialized neuroimagingâ€”is still in its early stages. A primary limitation is the current difficulty in non-invasively measuring glymphatic flow in humans, which has historically hindered research in this area.

## Conclusion & Future Work

The paper concludes that glymphatic system dysregulation offers a cohesive explanation for the multi-systemic nature of ME/CFS. The authors call for future research to prioritize the development of glymphatic-specific biomarkers and the use of advanced MRI techniques to visualize fluid movement in the brains of patients. They suggest that exploring treatments to enhance glymphatic drainage, such as vagus nerve stimulation ðŸ’Š or manual lymphatic therapies, could lead to much-needed breakthroughs in patient care.
